(-0.08%) 5 474.25 points
(-0.10%) 38 778 points
(-0.05%) 19 912 points
(0.22%) $80.51
(1.29%) $2.82
(0.23%) $2 334.30
(-0.19%) $29.34
(-0.20%) $969.00
(0.01%) $0.932
(-0.16%) $10.64
(0.07%) $0.788
(-1.86%) $86.81
Live Chart Being Loaded With Signals
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders...
Stats | |
---|---|
Šios dienos apimtis | 1.59M |
Vidutinė apimtis | 1.63M |
Rinkos kapitalizacija | 2.45B |
EPS | $0.100 ( Q1 | 2024-05-09 ) |
Kita pelno data | ( $0 ) 2024-07-31 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-40.11 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00900 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-08 | Schneyer Mark C. | Buy | 1 893 | Common Stock |
2024-06-10 | Schneyer Mark C. | Sell | 975 | Common Stock |
2024-06-08 | Schneyer Mark C. | Sell | 1 893 | Restricted Stock Units |
2024-05-29 | Ndu Adora | Buy | 15 959 | Director Stock Options (Right to Buy) |
2024-05-29 | Ndu Adora | Buy | 6 652 | Common Stock |
INSIDER POWER |
---|
60.99 |
Last 98 transactions |
Buy: 1 133 433 | Sell: 272 974 |
Tūris Koreliacija
ACADIA Pharmaceuticals Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
QNRX | 0.98 |
PRTS | 0.972 |
LPSN | 0.971 |
TTEC | 0.971 |
UONE | 0.97 |
APTO | 0.969 |
UONEK | 0.968 |
BCAN | 0.965 |
SVC | 0.965 |
DMTK | 0.964 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
OZEM | -1 |
ARYD | -0.973 |
RNA | -0.972 |
CRAI | -0.964 |
PNTG | -0.962 |
DAVE | -0.961 |
ESTA | -0.959 |
GHRS | -0.959 |
SHLD | -0.956 |
NTRA | -0.954 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
ACADIA Pharmaceuticals Koreliacija - Valiuta/Žaliavos
ACADIA Pharmaceuticals Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $726.44M |
Bruto pelnas: | $680.71M (93.70 %) |
EPS: | $-0.370 |
FY | 2023 |
Pajamos: | $726.44M |
Bruto pelnas: | $680.71M (93.70 %) |
EPS: | $-0.370 |
FY | 2022 |
Pajamos: | $517.24M |
Bruto pelnas: | $507.07M (98.03 %) |
EPS: | $-1.340 |
FY | 2021 |
Pajamos: | $484.15M |
Bruto pelnas: | $465.00M (96.05 %) |
EPS: | $-1.067 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.